NEW YORK (GenomeWeb) – Rare-disease non-profit group the Castleman Disease Collaborative Network said today that it is partnering with Janssen Research and Development in a proteomics study of patients with Castleman disease.

Specifically, the partners hope to improve diagnosis and treatment of one of the three subsets of the disorder, called idiopathic multicentric Castleman disease (iMCD).They plan to measure approximately 1,300 analytes in more than 260 serum samples collected from 100 iMCD patients at various time points during active disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.

Sponsored by

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.